Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateTimeSourceHeadlineSymbolCompany
26/07/201706:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTLAIntellia Therapeutics Inc
26/07/201706:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
25/07/201708:30GlobeNewswire Inc.Intellia Therapeutics Names Moncef Slaoui, Ph.D. and Frank Verwiel, M.D. to Its Board of Directors and Establishes a Science ...NASDAQ:NTLAIntellia Therapeutics Inc
12/07/201707:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
12/07/201707:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
19/06/201721:30GlobeNewswire Inc.Intellia Therapeutics Announces Patent for CRISPR/Cas Genome Editing in ChinaNASDAQ:NTLAIntellia Therapeutics Inc
19/06/201720:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NTLAIntellia Therapeutics Inc
06/06/201721:15GlobeNewswire Inc.Intellia Therapeutics and San Raffaele University and Research Hospital to Combine CRISPR/Cas9 Genome Editing with Enhanced C...NASDAQ:NTLAIntellia Therapeutics Inc
06/06/201707:09Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NTLAIntellia Therapeutics Inc
06/06/201707:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NTLAIntellia Therapeutics Inc
05/06/201722:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
05/06/201722:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
05/06/201722:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
05/06/201721:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
05/06/201721:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
05/06/201721:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
20/05/201707:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
20/05/201707:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
20/05/201707:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
20/05/201707:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
19/05/201707:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
13/05/201722:40GlobeNewswire Inc.Intellia Therapeutics Announces Progress with CRISPR/Cas9 at the American Society of Gene & Cell Therapy Annual MeetingNASDAQ:NTLAIntellia Therapeutics Inc
03/05/201706:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
02/05/201721:38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
02/05/201721:30GlobeNewswire Inc.Intellia Therapeutics Announces First Quarter 2017 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
26/04/201721:30GlobeNewswire Inc.Intellia Therapeutics and CRISPR Therapeutics Announce U.S. Patent Covering CRISPR/Cas9 Ribonucleoprotein ComplexesNASDAQ:NTLAIntellia Therapeutics Inc
19/04/201707:14Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NTLAIntellia Therapeutics Inc
13/04/201721:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
13/04/201721:30GlobeNewswire Inc.CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent B...NASDAQ:NTLAIntellia Therapeutics Inc
11/04/201721:30GlobeNewswire Inc.Intellia Therapeutics Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology PatentNASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA